Literature DB >> 32171023

Desloratadine and loratadine use associated with improved melanoma survival.

Ildikó Fritz1, Philippe Wagner1, Matteo Bottai2, Hanna Eriksson3,4,5, Christian Ingvar6, Isabelle Krakowski3,7, Kari Nielsen8, Håkan Olsson1,9.   

Abstract

Entities:  

Keywords:  chemotherapy; epidemiology; histamine antagonists; histamine H1 antagonists; pharmacology and pharmacogenomics

Mesh：

Substances：

Year:  2020        PMID： 32171023     DOI： 10.1111/all.14273

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  5 in total

1.  The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1.

Authors:  Hongzhong Li; Yi Xiao; Qin Li; Jun Yao; Xiangliang Yuan; Yuan Zhang; Xuedong Yin; Yohei Saito; Huihui Fan; Ping Li; Wen-Ling Kuo; Angela Halpin; Don L Gibbons; Hideo Yagita; Zhongming Zhao; Da Pang; Guosheng Ren; Cassian Yee; J Jack Lee; Dihua Yu
Journal:  Cancer Cell       Date:  2021-11-24       Impact factor: 31.743

2.  The Multidirectional Effect of Azelastine Hydrochloride on Cervical Cancer Cells.

Authors:  Ewa Trybus; Teodora Król; Wojciech Trybus
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

Review 3.  Mast Cells and Skin and Breast Cancers: A Complicated and Microenvironment-Dependent Role.

Authors:  Mark R Hanes; Carman A Giacomantonio; Jean S Marshall
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

4.  High regional mortality due to malignant melanoma in Eastern Finland may be explained by the increase in aggressive melanoma types.

Authors:  Ville Suhonen; Jaana Rummukainen; Hanna Siiskonen; Arto Mannermaa; Ilkka T Harvima
Journal:  BMC Cancer       Date:  2021-10-29       Impact factor: 4.430

Review 5.  OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.

Authors:  Richard E Kast; Marc-Eric Halatsch; Rafael Rosell
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.